Pharmaceutical Sales Data
Author: Kosta Tzavaras
Publisher: Trafford
Published: 2004
Total Pages: 207
ISBN-13: 9781412021937
DOWNLOAD EBOOK →Author: Kosta Tzavaras
Publisher: Trafford
Published: 2004
Total Pages: 207
ISBN-13: 9781412021937
DOWNLOAD EBOOK →Author: Kosta Tzavaras
Publisher: Trafford
Published: 2003
Total Pages: 273
ISBN-13: 9781412002707
DOWNLOAD EBOOK →Author: Tom Ruff
Publisher: Tom Ruff Company
Published: 2007
Total Pages: 236
ISBN-13: 0978607015
DOWNLOAD EBOOK →[This book is an] organized 'formulary' written for those who are considering a specific field - 'drug reps', as they are known in the industry.-Introd.
Author: Ben Goldacre
Publisher: Macmillan
Published: 2014-04
Total Pages: 479
ISBN-13: 0865478066
DOWNLOAD EBOOK →Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Author: Todd Bearden and Larry Martin
Publisher: iUniverse
Published: 2008-12
Total Pages: 102
ISBN-13: 1440109451
DOWNLOAD EBOOK →The most updated, comprehensive, real world, field manual on modern day pharmacuetical sales available today. This handbook was written by reps for reps. It was designed with you in mind, those that are out in the field everyday; selling and driving business for your company. This is not a handbook for getting into the industry or how to interview for your next pharmaceutical sales job, it is a boots on the ground field manual for success in this field, updated to include what the environment is like today and what it will be like in 5 years. As a retired military officer, I wish I had this book when I entered the industry eight years ago. Now you have the opportunity to hit the ground running with this field book, providing detailed information from being a standout in training to driving your sales beyond the competition in your first year in the field.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2018-03-01
Total Pages: 235
ISBN-13: 0309468086
DOWNLOAD EBOOK →Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Samuel D. Lamptey
Publisher: Troubador Publishing Ltd
Published: 2011-12-01
Total Pages: 105
ISBN-13: 1848767846
DOWNLOAD EBOOK →From Pharma to Device Sales is a concise, straight to the point pocket guide, enabling pharmaceutical sales people to move into the medical device sales arena. There is no other book available that explores how to successfully change industries. This guide has valuable insights from recent personal experiences, up-to-date material and useful statistics – to ensure a successful industry transition. Making the switch from pharmaceutical sales to medical devices can be an uphill struggle. Are you in pharmaceutical sales looking to cross over? Have you ever wondered what selling medical devices is really like? Do you know the vital differences between selling drugs and devices? Do you want to know the typical mistakes pharmaceutical sales people make at interviews and learn how to avoid such pitfalls? This book will provide all these answers and much more! From Pharma to Device Sales is a unique, concise and inspirational book. Whatever stage you are at in your pharma career, this is a must read.
Author: Todd Bearden
Publisher: iUniverse
Published: 2008-12-05
Total Pages: 100
ISBN-13: 9781440109461
DOWNLOAD EBOOK →The most updated, comprehensive, real world, field manual on modern day pharmacuetical sales available today. This handbook was written by reps for reps. It was designed with you in mind, those that are out in the field everyday; selling and driving business for your company. This is not a handbook for getting into the industry or how to interview for your next pharmaceutical sales job, it is a boots on the ground field manual for success in this field, updated to include what the environment is like today and what it will be like in 5 years. As a retired military officer, I wish I had this book when I entered the industry eight years ago. Now you have the opportunity to hit the ground running with this field book, providing detailed information from being a standout in training to driving your sales beyond the competition in your first year in the field.
Author: Konstantin V. Balakin
Publisher: John Wiley & Sons
Published: 2009-11-19
Total Pages: 584
ISBN-13: 0470567619
DOWNLOAD EBOOK →Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drug discovery and development In the era of post-genomic drug development, extracting and applying knowledge from chemical, biological, and clinical data is one of the greatest challenges facing the pharmaceutical industry. Pharmaceutical Data Mining brings together contributions from leading academic and industrial scientists, who address both the implementation of new data mining technologies and application issues in the industry. This accessible, comprehensive collection discusses important theoretical and practical aspects of pharmaceutical data mining, focusing on diverse approaches for drug discovery—including chemogenomics, toxicogenomics, and individual drug response prediction. The five main sections of this volume cover: A general overview of the discipline, from its foundations to contemporary industrial applications Chemoinformatics-based applications Bioinformatics-based applications Data mining methods in clinical development Data mining algorithms, technologies, and software tools, with emphasis on advanced algorithms and software that are currently used in the industry or represent promising approaches In one concentrated reference, Pharmaceutical Data Mining reveals the role and possibilities of these sophisticated techniques in contemporary drug discovery and development. It is ideal for graduate-level courses covering pharmaceutical science, computational chemistry, and bioinformatics. In addition, it provides insight to pharmaceutical scientists, principal investigators, principal scientists, research directors, and all scientists working in the field of drug discovery and development and associated industries.